Protalix BioTherapeutics
PLX
#8739
Rank
ยฃ0.12 B
Marketcap
ยฃ1.54
Share price
15.64%
Change (1 day)
-14.46%
Change (1 year)

Market capitalization of Protalix BioTherapeutics (PLX)

Market cap: ยฃ0.12 Billion

As of January 2026 Protalix BioTherapeutics has a market cap of ยฃ0.12 Billion. This makes Protalix BioTherapeutics the world's 8739th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Protalix BioTherapeutics from 1997 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ0.12 B14.72%
2025ยฃ0.10 B0.66%
2024ยฃ0.10 B5.35%
2023ยฃ0.10 B77.65%
2022ยฃ57.37 M104.4%
2021ยฃ28.06 M-68.38%
2020ยฃ88.77 M139.2%
2019ยฃ37.11 M2.09%
2018ยฃ36.35 M-46.82%
2017ยฃ68.35 M53.14%
2016ยฃ44.63 M-35.02%
2015ยฃ68.69 M-37.9%
2014ยฃ0.11 B-49.82%
2013ยฃ0.22 B-26.56%
2012ยฃ0.30 B10.54%
2011ยฃ0.27 B-48.04%
2010ยฃ0.52 B58.03%
2009ยฃ0.33 B246.93%
2008ยฃ95.32 M-26.49%
2007ยฃ0.12 B-75.38%
2006ยฃ0.52 B3565.49%
2005ยฃ14.37 M4631.43%
2004ยฃ0.3 M-53.41%
2003ยฃ0.65 M225.94%
2002ยฃ0.2 M-56.75%
2001ยฃ0.46 M-6.16%
2000ยฃ0.49 M-0.23%
1999ยฃ0.49 M-85.63%
1998ยฃ3.43 M-75.39%
1997ยฃ13.96 M

End of Day market cap according to different sources

On Jan 11th, 2026 the market cap of Protalix BioTherapeutics was reported to be:

ยฃ0.12 Billion
by Nasdaq info icon info icon
ยฃ0.12 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amicus Therapeutics
FOLD
ยฃ3.28 B 2,553.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ10.08 B 8,032.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ107.90 B 86,924.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ27.35 B 21,960.50%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel